InMode Ltd vs JPMorgan Ultra Short Income ETF — how do they compare? InMode Ltd trades at $14.14 (market cap $809.93M), while JPMorgan Ultra Short Income ETF trades at $50.29 (market cap $42.37B). The key difference: JPMorgan Ultra Short Income ETF is far larger — about 52.3× InMode Ltd's market cap, and InMode Ltd is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 29 Days and JPMorgan Ultra Short Income ETF for 46 Days on average.
| INMD | JPST | |
|---|---|---|
Market Cap | $809.93M | $42.37B |
Volume | 365,490 | 7,889,185 |
Sector | Health | Fixed Income |
52-Week High | $16.62 | $50.78 |
52-Week Low | $12.76 | $50.22 |
Typical Hold Time | 29 Days | 46 Days |
Enterprise Value | $313.27M | — |
Signals from Pluang's Aura AI — not financial advice
INMD trades at $14.01, up 0.14% on the day, with a bearish technical signal from moving averages and oscillators. The company reported Q2 2026 earnings of $0.35 per share, beating expectations, and maintains a strong gross profit margin of 76.52%. Recent news includes the launch of Morpheus8 Cool and an unsolicited acquisition offer from Steel Partners at $16.75 per share.
The outlook is mixed: valuation metrics like P/E of 11.63 and EV/EBITDA of 4.48 appear attractive, but declining net income and bearish technicals pose risks. Analyst consensus is divided with 45.45% buy ratings, highlighting potential upside from strategic developments against execution challenges.
JPMorgan Ultra-Short Income ETF (JPST) trades at $50.27 with minimal daily movement (+0.04%). The ETF shows bearish technical signals with moving averages indicating selling pressure, though oscillators remain neutral. Recent institutional activity shows mixed sentiment with some firms reducing positions while others increased holdings. The fund continues its regular $0.17 dividend payments, maintaining income distribution consistency.
JPST faces headwinds from rising interest rate environment while benefiting from demand for ultra-short duration strategies. The ETF's active management approach has shown recent underperformance versus peers, creating both opportunity for yield-seeking investors and risk from competitive pressure. Market volatility continues to drive flows into cash-alternative strategies.
Trailing returns across standard periods
Latest headlines on both assets
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →